News Announcement

Ipca Laboratories: Board Meeting Intimation for Integration And Consolidation Of The Generics Formulations Business In The US Market

IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2024 inter alia to consider and approve Integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Companys subsidiary)


दूसरी कैटेगरी